- 1、本文档共52页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
* * * * Major clinical trials have demonstrated that patients typically needed treatment with multiple antihypertensive agents to get to, and stay at, BP goal. The number of antihypertensive agents required for BP control in many patients typically averages 2?4, with co-morbid conditions (such as kidney disease or diabetes mellitus) imposing greater drug requirement.1,2 For example, in the Hypertension Optimal Treatment (HOT) study, an average of 3.3 drugs were required to attain a diastolic BP goal of 80 mmHg, and in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA), most patients were taking at least two antihypertensive agents by the end of the trial.2,3 In the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial, patients were receiving initial treatment with single-pill combinations of antihypertensive agents. Excellent BP control rates were obtained with both the single-pill combinations used in the study.4 References 1. Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension. The cycle repeats. Drugs 2002;62:443?62. 2. Bakris GL, et al. The importance of blood pressure control in the patient with diabetes. Am J Med 2004;116(5A):30S–8S. 3. Dahl?f B, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895?906. 4. Jamerson K, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417?28. * 联合治疗 新指南指出基线血压显著升高或者CV高风险的患者应考虑起始两种联合治疗。两种RAS阻断剂的联合不被推荐及鼓励。其他药物联合在某种程度上都能更大程度的降压带来获益,然而应优先考虑在大型研究中成功应用(具有循证证据)的药物联合方案。高血压患者的治疗依从性低,两种药物的固定复方制剂通过减少每日服药数量改善依从性,因此优先推荐。 指南首次以表格形式汇总了不同药物联合的终点研究循证证据,其中ARB+D的循证证据为
您可能关注的文档
最近下载
- 2021年二建《水利》重要考点.pdf VIP
- (正式版)HG∕T 20644-2024 弹簧支吊架选用标准.pdf VIP
- DBJ43_T341-2019:轻钢模网改性聚苯颗粒混凝土结构技术规程.pdf VIP
- 地质图用色标准及用色原则(完整版).pdf VIP
- 慧商斯威课程介绍慧商斯威课介绍.pdf
- 《成人糖尿病食养指南(2023年版)》解读PPT课件.pptx VIP
- +陕西省西安市经开区2023-2024学年七年级下学期期中考试数学试卷+.docx VIP
- 幼儿园课件《换牙我不怕》.ppt VIP
- DB53T 1348.2-2025永生花(保真花)加工技术规范 第2部分:基础管理.pdf VIP
- 文化认同对青少年社会化过程的影响教学研究课题报告.docx
文档评论(0)